| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.0M | — | +15.4% |
| Cost of Revenue | $1.6M | — | +129.7% |
| Gross Profit | $1.8M | — | +1077.3% |
| R&D Expense | $14.1M | — | +111.0% |
| SG&A Expense | $14.1M | — | +5789.6% |
| Operating Income | -$27.0M | — | — |
| Pre-tax Income | -$90.4M | — | -609.8% |
| Income Tax | $48K | — | +4700.0% |
| Net Income | -$90.4M | — | -3841.4% |
| EPS (Basic) | -$1.27 | — | -605.6% |
| EPS (Diluted) | -$1.27 | — | -605.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $325K | -1.5% | — |
| Accounts Receivable | $1.3M | +264.7% | — |
| Current Assets | $130.0M | — | +5991.4% |
| Total Assets | $145.4M | -44.8% | -43.4% |
| Current Liabilities | $14.9M | +347.8% | +1287.3% |
| Long-term Debt | $32.1M | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$23.6M | — | -9887.7% |
| Capital Expenditures | $2.2M | — | +2196.8% |
| Investing Cash Flow | -$2.2M | — | -2632.9% |
| Financing Cash Flow | $91.8M | — | +6034.5% |
| Free Cash Flow | -$25.8M | — | -7701.8% |
| — |
| Total Liabilities | $104.2M | +762.2% | +960.1% |
| Stockholders' Equity | -$139.1M | -1145.8% | -1734.1% |